| P2093 | author name string | Saverio Gentile | |
| P2860 | cites work | Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development | Q24646866 |
| | hERG channel function: beyond long QT | Q27008078 |
| | Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 | Q28145423 |
| | THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS | Q28202269 |
| | Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes | Q28291447 |
| | Mutational landscape and significance across 12 major cancer types | Q28300353 |
| | A structural basis for drug-induced long QT syndrome | Q28344808 |
| | HERG K+ channel-dependent apoptosis and cell cycle arrest in human glioblastoma cells | Q28539628 |
| | Regulation of an ERG K+ current by Src tyrosine kinase | Q28581012 |
| | Homozygous missense N629D hERG (KCNH2) potassium channel mutation causes developmental defects in the right ventricle and its outflow tract and embryonic lethality. | Q30491532 |
| | Sudden arrhythmia death syndrome: importance of the long QT syndrome. | Q33149251 |
| | Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I(Ks). | Q33661049 |
| | Four faces of cellular senescence. | Q34025754 |
| | Modulation of the ERG K+ current by the tyrosine phosphatase, SHP-1. | Q34152898 |
| | Expression and role of hERG channels in cancer cells. | Q34437815 |
| | hERG potassium channels and cardiac arrhythmia | Q34504394 |
| | Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients | Q34621219 |
| | Stimulation of hERG1 channel activity promotes a calcium-dependent degradation of cyclin E2, but not cyclin E1, in breast cancer cells | Q35176400 |
| | ERG conductance expression modulates the excitability of ventral horn GABAergic interneurons that control rhythmic oscillations in the developing mouse spinal cord | Q79655193 |
| | [Novel methylation and expression markers associated with breast cancer] | Q81441557 |
| | Is erythromycin therapy teratogenic in humans? | Q81770658 |
| | Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits | Q82768867 |
| | E- and A-type cyclins as markers for cancer diagnosis and prognosis | Q35543902 |
| | Choosing the right cell line for breast cancer research | Q35608671 |
| | Embryonic cardiac arrhythmia and generation of reactive oxygen species: common teratogenic mechanism for IKr blocking drugs | Q36849934 |
| | Potassium channel activation inhibits proliferation of breast cancer cells by activating a senescence program | Q36973723 |
| | Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel | Q36975149 |
| | Activation of hERG3 channel stimulates autophagy and promotes cellular senescence in melanoma | Q37225455 |
| | Targeting ion channels in cancer: a novel frontier in antineoplastic therapy | Q37370358 |
| | Assessing proarrhythmic potential of drugs when optimal studies are infeasible. | Q37450211 |
| | Voltage-gated potassium channels as therapeutic targets | Q37464784 |
| | hERG1/Kv11.1 activation stimulates transcription of p21waf/cip in breast cancer cells via a calcineurin-dependent mechanism | Q37644785 |
| | Role of autophagy in cancer prevention | Q37898320 |
| | hERG K(+) channels: structure, function, and clinical significance | Q38044402 |
| | Role of autophagy in cancer prevention, development and therapy | Q38144288 |
| | Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells | Q38361021 |
| | Inhibition of HERG1 K+ channel protein expression decreases cell proliferation of human small cell lung cancer cells | Q39444757 |
| | Human ether-à-go-go-related gene expression is essential for cisplatin to induce apoptosis in human gastric cancer | Q39454149 |
| | Electrophysiological effects of the anti-cancer drug lapatinib on cardiac repolarization | Q39712812 |
| | Expression and significance of HERG (KCNH2) potassium channels in the regulation of MDA-MB-435S melanoma cell proliferation and migration | Q39797663 |
| | Silencing of herg gene by shRNA inhibits SH-SY5Y cell growth in vitro and in vivo | Q40058589 |
| | Characterization of Erg K+ channels in alpha- and beta-cells of mouse and human islets | Q42060620 |
| | Arsenic trioxide-induced hERG K(+) channel deficiency can be rescued by matrine and oxymatrine through up-regulating transcription factor Sp1 expression | Q42715022 |
| | Regulation of the voltage-insensitive step of HERG activation by extracellular pH. | Q43110152 |
| | Erg K+ currents modulate excitability in mouse mitral/tufted neurons | Q43290379 |
| | Blocking of the human ether-à-go-go-related gene channel by imatinib mesylate | Q43514924 |
| | Embryonic arrhythmia by inhibition of HERG channels: a common hypoxia-related teratogenic mechanism for antiepileptic drugs? | Q44004456 |
| | ERG K+ channel blockade enhances firing and epinephrine secretion in rat chromaffin cells: the missing link to LQT2-related sudden death? | Q44254910 |
| | Expression and function of KCNH2 (HERG) in the human jejunum | Q44433185 |
| | Effect of Arsenic Trioxide on QT Interval in Patients With Advanced Malignancies | Q44598288 |
| | Ether-à-go-go-related gene K+ channels contribute to threshold excitability of mouse auditory brainstem neurons | Q46054857 |
| | The potent inhibitory effects of cisapride, a specific blocker for human ether-a-go-go-related gene (HERG) channel, on gastric cancer cells | Q46450387 |
| | Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome | Q46681639 |
| | Drug binding interactions in the inner cavity of HERG channels: molecular insights from structure-activity relationships of clofilium and ibutilide analogs | Q46807818 |
| | HERG- and IRK-like inward rectifier currents are sequentially expressed during neuronal development of neural crest cells and their derivatives | Q48501900 |
| | herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? | Q48945547 |
| | erg gene(s) expression during development of the nervous and muscular system of quail embryos. | Q52166642 |
| | Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. | Q52590496 |
| | Arsenic trioxide inhibits breast cancer cell growth via microRNA-328/hERG pathway in MCF-7 cells. | Q53564372 |
| | HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors. | Q53866705 |
| | Imatinib has the potential to exert its antileukemia effects by down-regulating hERG1 K+ channels in chronic myelogenous leukemia. | Q54334505 |
| | Expression and Role of hERG Channels in Cancer Cells | Q56420805 |
| | Screening for mutations and polymorphisms in the genes KCNH2 and KCNE2 encoding the cardiac HERG/MiRP1 ion channel: implications for acquired and congenital long Q-T syndrome | Q57807317 |
| | Glucose- and arginine-induced insulin secretion by human pancreatic beta-cells: the role of HERG K(+) channels in firing and release | Q73251237 |
| P433 | issue | 7 | |
| P304 | page(s) | 649-655 | |
| P577 | publication date | 2016-09-20 | |
| P1433 | published in | European Biophysics Journal | Q5412316 |
| P1476 | title | hERG1 potassium channel in cancer cells: a tool to reprogram immortality | |
| P478 | volume | 45 | |